Skip to main content
Journal cover image

Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program

Publication ,  Conference
Allen, LA; Felker, GM; Pocock, SJ; McMurray, JJV; Pfeffer, MA; Swedberg, K; Wang, D; Yusuf, S; Michelson, EL; Granger, CB
Published in: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
March 6, 2007

Duke Scholars

Published In

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ISSN

0735-1097

Publication Date

March 6, 2007

Volume

49

Issue

9

Start / End Page

44A / 44A

Location

New Orleans, LA

Publisher

ELSEVIER SCIENCE INC

Conference Name

56th Annual Scientific Session of the American-College-of-Cardiology

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Allen, L. A., Felker, G. M., Pocock, S. J., McMurray, J. J. V., Pfeffer, M. A., Swedberg, K., … Granger, C. B. (2007). Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 49, pp. 44A-44A). New Orleans, LA: ELSEVIER SCIENCE INC.
Allen, Larry A., G Michael Felker, Stuart J. Pocock, John J. V. McMurray, Marc A. Pfeffer, Karl Swedberg, Duolao Wang, Salim Yusuf, Eric L. Michelson, and Christopher B. Granger. “Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 49:44A-44A. ELSEVIER SCIENCE INC, 2007.
Allen LA, Felker GM, Pocock SJ, McMurray JJV, Pfeffer MA, Swedberg K, et al. Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2007. p. 44A-44A.
Allen, Larry A., et al. “Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 49, no. 9, ELSEVIER SCIENCE INC, 2007, pp. 44A-44A.
Allen LA, Felker GM, Pocock SJ, McMurray JJV, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB. Liver function test abnormalities and outcome in patients with chronic heart failure: Data from the candesartan in heart failure assessment of reduction in mortality and morbidity (CHARM) program. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2007. p. 44A-44A.
Journal cover image

Published In

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

ISSN

0735-1097

Publication Date

March 6, 2007

Volume

49

Issue

9

Start / End Page

44A / 44A

Location

New Orleans, LA

Publisher

ELSEVIER SCIENCE INC

Conference Name

56th Annual Scientific Session of the American-College-of-Cardiology

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1102 Cardiorespiratory Medicine and Haematology